Anthropic Launches Claude Science, Plans Own Drug Development
▶ The 2-minute explainer
Summary
Anthropic introduced Claude Science, an AI workbench for scientists that unifies tools and datasets, and announced its intention to develop its own drugs. The company highlights AI's potential to accelerate scientific discovery and healthcare interventions.
Why it matters
This development signifies a major AI company moving from providing tools to direct application in a highly regulated and impactful industry, potentially revolutionizing drug discovery and scientific research.
How to implement this in your domain
- 1Explore Claude Science as a potential platform for consolidating research tools and datasets within your scientific or R&D department.
- 2Assess the capabilities of Claude's AI models for accelerating specific stages of scientific discovery, such as hypothesis generation or data analysis.
- 3Monitor Anthropic's progress in drug development to understand new AI-driven R&D paradigms and competitive shifts.
- 4Consider partnerships or collaborations with AI companies to integrate advanced AI into your own scientific workflows.
Who benefits
Key takeaways
- Anthropic launched Claude Science, an AI workbench for scientists.
- The platform integrates tools and datasets, generating visuals.
- Anthropic aims to accelerate scientific discovery and healthcare interventions.
- The company also plans to develop its own drugs.
Original post by AI | The Verge
"At the event "The Briefing: AI for Science" earlier this week, Anthropic announced Claude Science, a new "AI workbench for scientists" that pulls fragmented tools and datasets into one environment, and generates figures and visuals. Anthropic, already dominating the industry with…"
View on XOriginally posted by AI | The Verge on X · view source
Want to go deeper?
Turn these trends into skills with Learnijoy's hands-on AI & tech courses.
Explore coursesMore in AI News & Tools
Community Member Creates Physical Claude Model Gear Shifter
An individual developed a physical gear shifter mechanism that allows users to switch between different Claude AI models. This creative solution highlights the innovative spirit within the AI community.

Major Tech News Digest: Sony, Apple, Google, and Lilly Updates
Today's top tech stories include Sony discontinuing PlayStation discs, Apple's plans for five new iPhones contingent on chip availability, Google's significant loss in an Android antitrust case, and Lilly targeting hair loss with a new injectable. The digest also covers other quick tech news hits.

Funding Drives AI Intelligence Scaling Paradigm
The post suggests a direct correlation between increased financial investment and advancements in AI intelligence, framing it as the primary scaling model for artificial intelligence.